Bringing the Oncology Community Together
Glycans Emerge as Promising Biomarkers for Early Detection of Many Cancer Types
For many years, we in the medical and research communities have tried to use proteins and DNA fragments as disease markers to find cancer early.
Read More >>
Bevacizumab Receives Priority Review in Ovarian Cancer
Immunotherapy Branches Out
FDA Grants Priority Review to Bevacizumab in Advanced Cervical Cancer
Aggressive Ovarian Cancer Tracked to Inactivating Tumor Mutations
ODAC Votes Against Maintenance Olaparib in BRCA-Positive Ovarian Cancer
Mutations in Ovarian Cancer More Frequent, Varied Than Estimated
View More >>
- A Network of Your Peers
View more >>
Dr. Dowdy on the Association of Molecular Subtypes and Responses to Bevacizumab in Ovarian Cancer
Dr. Monk on Bevacizumab in Recurrent Cervical Cancer
Dr. Hyman on MEDI3617 as Potential Treatment for Patients with Advanced Solid Tumors
Most Popular Right Now
Tweets by @OncLive
Support and Assistance for Patients with Cancer
Useful information on supporting and assisting patients with cancer.
Community Practice Connections: 9th Annual International Symposium on Ovarian Cancer and Gynecologic Malignancies
CME activity worth 1.0 CME credits led by James Tate Thigpen, MD.
American Journal of Managed Care
Oncology Nursing News
Physicians' Education Resource
Physician's Money Digest
Specialty Pharmacy Times
Terms & Conditions
666 Plainsboro Road
Plainsboro, NJ 08536
Copyright OncLive 2006-2014
Intellisphere, LLC. All Rights Reserved.